Adjuvant treatment with sodium selenite in gynecologic radiation oncology: First results of a phase III study

被引:0
|
作者
Muecke, R
Glatzel, M
Bernd-Skorka, R
Seifert, G
Buentzel, J
Schoenekaes, KG
Bruns, F
Kisters, K
Prott, F
Micke, O
机构
[1] St Josefs Hosp, Wiesbaden, Germany
[2] Suhl Cent Hosp, Suhl, Germany
[3] Neubrandenburg Hosp, Neubrandenburg, Germany
[4] Chemnitz Hosp, Chemnitz, Germany
[5] Suedharz Hosp, Nordhausen, Germany
[6] Minden Hosp, Minden, Germany
[7] Hannover Med Univ Hosp, Hannover, Germany
[8] St Anna Hosp, Herne, Germany
[9] Munster Univ Hosp, Munster, Germany
关键词
D O I
10.1016/j.ijrobp.2005.07.376
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1122
引用
收藏
页码:S218 / S219
页数:2
相关论文
共 50 条
  • [21] The study of possible application of sodium selenite as an adjuvant in lithium treatment: an effect on oxidative processes in heart of rats
    Kielczykowska, M.
    Kocot, J.
    Zelazowska, R.
    Lewandowska, A.
    Musik, I.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (20) : 3947 - 3954
  • [22] CERVICAL CANCER TREATMENT CAPACITY IN AFRICA: MAPPING OF RADIATION ONCOLOGY AND GYNECOLOGIC ONCOLOGY SERVICES
    Allanson, Emma
    Akinfenwa, Chidinma Anakwenze
    Ewongwo, Agnes
    Bazzett-Matabele, Lisa
    Msadabwe, Susan
    Kamfwa, Paul
    Shouman, Tarek
    Lombe, Dorothy
    Rubagumya, Fidel
    Rubio, Alfredo Polo
    Ntekim, Atara
    Vanderpuye, Verna
    Ghebre, Rahel
    Kochbati, Lotfi
    Awol, Munir
    Abdel-Wahab, May
    Trimble, Edward
    Schmeler, Kathleen
    Simonds, Hannah
    Grover, Surbhi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A64 - A65
  • [23] Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813
    Chang, Susan
    Zhang, Peixin
    Cairncross, J. Gregory
    Gilbert, Mark R.
    Bahary, Jean-Paul
    Dolinskas, Carol A.
    Chakravarti, Arnab
    Aldape, Kenneth D.
    Bell, Erica H.
    Schiff, David
    Jaeckle, Kurt
    Brown, Paul D.
    Barger, Geoffrey R.
    Werner-Wasik, Maria
    Shih, Helen
    Brachman, David
    Penas-Prado, Marta
    Robins, H. Ian
    Belanger, Karl
    Schultz, Christopher
    Hunter, Grant
    Mehta, Minesh
    NEURO-ONCOLOGY, 2017, 19 (02) : 252 - 258
  • [24] A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
    Keys, HM
    Roberts, JA
    Brunetto, VL
    Zaino, RJ
    Spirtos, NM
    Bloss, JD
    Pearlman, A
    Maiman, MA
    Bell, JG
    GYNECOLOGIC ONCOLOGY, 2004, 92 (03) : 744 - 751
  • [25] A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082)
    Furusawa, Akiko
    Takekuma, Munetaka
    Mori, Keita
    Usami, Tomoka
    Kondo, Eiji
    Nishio, Shin
    Nishino, Koji
    Miyamoto, Yuichiro
    Yoshimura, Ryoichi
    Watanabe, Miho
    Mikami, Mikio
    Enomoto, Takayuki
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (04) : 623 - 626
  • [26] Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study
    Bell, Jeffrey
    Brady, Mark F.
    Young, Robert C.
    Lage, Janice
    Walker, Joan L.
    Look, Katherine Y.
    Rose, G. Scott
    Spirtos, Nick M.
    GYNECOLOGIC ONCOLOGY, 2006, 102 (03) : 432 - 439
  • [27] Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: A Gynecologic Oncology Group study
    Homesley, Howard D.
    Filiaci, Virginia
    Markman, Maurie
    Bitterman, Pincas
    Eaton, Lynne
    Kilgore, Larry C.
    Monk, Bradley J.
    Ueland, Frederick R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) : 526 - 531
  • [28] Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: A gynecologic oncology group study
    Thigpen, JT
    Brady, MF
    Homesley, HD
    Malfetano, J
    DuBeshter, B
    Burger, RA
    Liao, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) : 3902 - 3908
  • [29] Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology - a subgroup analysis of a multicenter, phase III trial
    Ralph Muecke
    Oliver Micke
    Lutz Schomburg
    Jens Buentzel
    Michael Glatzel
    Dieter Baaske
    Regina Berndt-Skorka
    Franz J Prott
    Berthold Reichl
    Klaus Kisters
    Ulrich Schaefer
    Jutta Huebner
    Hans Th Eich
    Guenther Kundt
    Irenaeus A Adamietz
    Radiation Oncology, 8
  • [30] Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology - a subgroup analysis of a multicenter, phase III trial
    Muecke, Ralph
    Micke, Oliver
    Schomburg, Lutz
    Buentzel, Jens
    Glatzel, Michael
    Baaske, Dieter
    Berndt-Skorka, Regina
    Prott, Franz J.
    Reichl, Berthold
    Kisters, Klaus
    Schaefer, Ulrich
    Huebner, Jutta
    Eich, Hans Th
    Kundt, Guenther
    Adamietz, Irenaeus A.
    RADIATION ONCOLOGY, 2013, 8